Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 82
11.
  • NEDA-3 achievement in early... NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
    Signoriello, Elisabetta; Signori, Alessio; Lus, Giacomo ... Multiple sclerosis and related disorders, 07/2024, Letnik: 87
    Journal Article
    Odprti dostop

    •High-efficacy disease-modifying therapy (HE DMTs) may represent an optimal strategy for delaying neurological damage and long-term disease progression.•Ocrelizumab and natalizumab could be the best ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP
12.
  • Influenza Vaccine Hesitancy... Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study
    Ziello, Antonio; Scavone, Cristina; Di Battista, Maria Elena ... Brain sciences, 07/2021, Letnik: 11, Številka: 7
    Journal Article
    Recenzirano
    Odprti dostop

    Background. The so-called “vaccine hesitancy” still represents a common phenomenon that undermines the effectiveness of vaccination campaigns. In 2020, the Italian Medicines Agency recommended to ...
Celotno besedilo
Dostopno za: IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK

PDF
13.
  • Three Doses of COVID-19 Vac... Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis
    Maniscalco, Giorgia Teresa; Di Giulio Cesare, Daniele; Liguori, Valerio ... Journal of clinical medicine, 06/2023, Letnik: 12, Številka: 13
    Journal Article
    Recenzirano
    Odprti dostop

    Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
14.
  • The Safety Profile of COVID... The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study
    Maniscalco, Giorgia Teresa; Scavone, Cristina; Mascolo, Annamaria ... Journal of clinical medicine, 11/2022, Letnik: 11, Številka: 22
    Journal Article
    Recenzirano
    Odprti dostop

    In the current COVID-19 pandemic, patients diagnosed with multiple sclerosis (MS) are considered to be one of the highest priority categories, being recognized as extremely vulnerable people. For ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
15.
  • Preliminary Results of the ... Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
    Maniscalco, Giorgia Teresa; Brescia Morra, Vincenzo; Florio, Ciro ... Pharmaceuticals (Basel, Switzerland), 12/2020, Letnik: 13, Številka: 12
    Journal Article
    Recenzirano
    Odprti dostop

    Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM ...
Celotno besedilo
Dostopno za: IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK

PDF
16.
  • Prognostic Markers of Ocrel... Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
    Lanzillo, Roberta; Carotenuto, Antonio; Signoriello, Elisabetta ... Journal of clinical medicine, 04/2022, Letnik: 11, Številka: 8
    Journal Article
    Recenzirano
    Odprti dostop

    Pivotal trials showed the effectiveness of the monoclonal antibody ocrelizumab in relapsing and progressive multiple sclerosis (MS). However, data on everyday practice in MS patients and markers of ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
17.
  • Glycolysis controls the ind... Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
    De Rosa, Veronica; Galgani, Mario; Porcellini, Antonio ... Nature immunology, 11/2015, Letnik: 16, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Human regulatory T cells (T(reg) cells) that develop from conventional T cells (T(conv) cells) following suboptimal stimulation via the T cell antigen receptor (TCR) (induced T(reg) cells (iT(reg) ...
Celotno besedilo
Dostopno za: DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SBMB, SIK, UILJ, UKNU, UL, UM, UPUK

PDF
18.
  • Cognitive impairment at dia... Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression
    Moccia, Marcello; Lanzillo, Roberta; Palladino, Raffaele ... Multiple sclerosis, 04/2016, Letnik: 22, Številka: 5
    Journal Article
    Recenzirano

    Background: Cognitive impairment occurs from the early phases of multiple sclerosis (MS), and more frequently affects secondary progressive (SP) subjects than relapsing–remitting (RR). Objective: To ...
Celotno besedilo
Dostopno za: NUK, OILJ, SAZU, UKNU, UL, UM, UPUK
19.
  • Progression is independent ... Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study
    Portaccio, Emilio; Bellinvia, Angelo; Fonderico, Mattia ... Brain (London, England : 1878), 08/2022, Letnik: 145, Številka: 8
    Journal Article
    Recenzirano
    Odprti dostop

    Disability accrual in multiple sclerosis may occur as relapse-associated worsening or progression independent of relapse activity. The role of progression independent of relapse activity in early MS ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
20.
Celotno besedilo
Dostopno za: CMK

PDF
1 2 3 4 5
zadetkov: 82

Nalaganje filtrov